Prevalence of lymphedema among Anderson-Fabry disease patients: A report from the Fabry registry

Molecular Genetics and Metabolism - Tập 138 - Trang 107538 - 2023
Deya Alkhatib1, Jesus Avila Vega2, Issa Pour-Ghaz1, Omar Al-Taweel3, Sania Khan1, Kimberly DeCarr4, Anandbir Bath1, Aranyak Rawal1, David Wilbanks2, Joel Raja1, Asra Butt1, Neeraja Yedlapati1, Robert J. Hopkin5,6, John L. Jefferies1
1Division of Cardiovascular Disease, University of Tennessee Health Science Center, Memphis, TN 38163, USA
2Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA
3Cardiology, Las Vegas School of Medicine, University of Nevada, Las Vegas, NV 89154, USA
4The University of Tennessee Health Science Center – College of Medicine, Memphis, TN 38163, USA
5Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
6Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA

Tài liệu tham khảo

Adeboye, 2022, The cardiovascular manifestations of Anderson-Fabry disease, Curr. Cardiovasc. Risk Rep., 16, 43, 10.1007/s12170-022-00691-1 Zarate, 2008, Fabry’s disease, Lancet., 372, 1427, 10.1016/S0140-6736(08)61589-5 Tuttolomondo, 2013, Anderson-Fabry disease: a multiorgan disease, Curr. Pharm. Des., 19, 5974, 10.2174/13816128113199990352 Giuseppe, 2013, Cutaneous complications of Anderson-Fabry disease, Curr. Pharm. Des., 19, 6031, 10.2174/13816128113199990359 Hopkin, 2008, Characterization of Fabry disease in 352 pediatric patients in the Fabry registry, Pediatr. Res., 64, 550, 10.1203/PDR.0b013e318183f132 Orteu, 2007, Fabry disease and the skin: data from FOS, the Fabry outcome survey, Br. J. Dermatol., 157, 331, 10.1111/j.1365-2133.2007.08002.x Desnick, 2003, Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy, Ann. Intern. Med., 138, 338, 10.7326/0003-4819-138-4-200302180-00014 Wise, 1962, Angiokeratoma corporis diffusum. A clinical study of eight affected families, Q. J. Med., 31, 177 MacDermot, 2001, Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males, J. Med. Genet., 38, 750, 10.1136/jmg.38.11.750 Whybra, 2001, Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes, J. Inherit. Metab. Dis., 24, 715, 10.1023/A:1012993305223 MacDermot, 2001, Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females, J. Med. Genet., 38, 769, 10.1136/jmg.38.11.769 Galanos, 2002, Clinical features of Fabry’s disease in Australian patients, Intern. Med. J., 32, 575, 10.1046/j.1445-5994.2002.00291.x Amann-Vesti, 2003, Severe lymphatic microangiopathy in Fabry disease, Lymphat. Res. Biol., 1, 185, 10.1089/153968503768330229 Lidove, 2016, Musculoskeletal manifestations of Fabry disease: a retrospective study, Joint Bone Spine., 83, 421, 10.1016/j.jbspin.2015.11.001 Fabry Disease Registry Saito, 2011, Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease, J. Hum. Genet., 56, 467, 10.1038/jhg.2011.31 Rockson, 2008, Diagnosis and management of lymphatic vascular disease, J. Am. Coll. Cardiol., 52, 799, 10.1016/j.jacc.2008.06.005
Thông tin
Thông tin xuất bản

Molecular Genetics and Metabolism

Tập 138

107538

Thông tin tác giả